Cargando…

Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis

The protozoan parasite Trypanosoma brucei causes the fatal illness human African trypanosomiasis (HAT). Standard of care medications currently used to treat HAT have severe limitations, and there is a need to find new chemical entities that are active against infections of T. brucei. Following a “dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Sarah M., Purmal, Andrei, Pollastri, Michael, Mensa-Wilmot, Kojo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000474/ https://www.ncbi.nlm.nih.gov/pubmed/27561392 http://dx.doi.org/10.1038/srep32083

Ejemplares similares

Erratum: Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis
por: Thomas, Sarah M., et al.
Publicado: (2017)

Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery
por: Singh, Baljinder, et al.
Publicado: (2023)

Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds
por: Katiyar, Samiksha, et al.
Publicado: (2013)

Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites
por: Devine, William, et al.
Publicado: (2017)

Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014)

A fixable probe for visualizing flagella and plasma membranes of the African trypanosome
por: Wiedeman, Justin, et al.
Publicado: (2018)

Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome
por: Kumar, Gaurav, et al.
Publicado: (2022)

Phenotypic Drug Discovery for Human African Trypanosomiasis: A Powerful Approach
por: Buckner, Frederick S., et al.
Publicado: (2020)

Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery
por: Devine, William, et al.
Publicado: (2015)

Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis
por: Lamour, Sabrina D., et al.
Publicado: (2015)

Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT)
por: Koester, Dennis C., et al.
Publicado: (2022)

Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter
por: GILBERT, IAN H.
Publicado: (2014)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome
por: Sharma, Amrita, et al.
Publicado: (2022)

The Burden of Human African Trypanosomiasis
por: Fèvre, Eric M., et al.
Publicado: (2008)

Chemotherapy of Human African Trypanosomiasis
por: Bacchi, Cyrus J.
Publicado: (2009)

Epidemiology of human African trypanosomiasis
por: Franco, Jose R, et al.
Publicado: (2014)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Casein kinase TbCK1.2 regulates division of kinetoplast DNA, and movement of basal bodies in the African trypanosome
por: Sullenberger, Catherine, et al.
Publicado: (2021)

Chemotherapy for second‐stage human African trypanosomiasis: drugs in use
por: Lutje, Vittoria, et al.
Publicado: (2021)

Diacylglycerol-Stimulated Endocytosis of Transferrin in Trypanosomatids Is Dependent on Tyrosine Kinase Activity
por: Subramanya, Sandesh, et al.
Publicado: (2010)

An approach to the development of new drugs for African trypanosomiasis
Publicado: (1978)

Towards the Atlas of human African trypanosomiasis
por: Cecchi, Giuliano, et al.
Publicado: (2009)

Generation of neuroinflammation in human African trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2019)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis
por: Barrett, Michael P.
Publicado: (2018)

Trypanosoma brucei Interaction with Host: Mechanism of VSG Release as Target for Drug Discovery for African Trypanosomiasis
por: Moreno, Cláudia Jassica Gonçalves, et al.
Publicado: (2019)

The history of African trypanosomiasis
por: Steverding, Dietmar
Publicado: (2008)

African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase
por: West, Ryan A., et al.
Publicado: (2017)

Human African Trypanosomiasis in Areas without Surveillance
por: Chappuis, François, et al.
Publicado: (2010)

Immunophenotypic Lymphocyte Profiles in Human African Trypanosomiasis
por: Boda, Caroline, et al.
Publicado: (2009)

Urban Transmission of Human African Trypanosomiasis, Gabon
por: Simon, Fabrice, et al.
Publicado: (2012)

Human African trypanosomiasis control: Achievements and challenges
por: Aksoy, Serap, et al.
Publicado: (2017)

Kynurenine Pathway Activation in Human African Trypanosomiasis
por: Sternberg, Jeremy M., et al.
Publicado: (2017)

Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
por: Kennedy, Peter G. E., et al.
Publicado: (2019)

Genetic and immunological basis of human African trypanosomiasis
por: Pays, Etienne, et al.
Publicado: (2021)

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

Prevalence of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Mumba, Dieudonne, et al.
Publicado: (2011)

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
por: Dickie, Emily A., et al.
Publicado: (2020)

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
por: Imran, Mohd, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mvh5tm8f139af95n5d2ua9arj6